• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A comparison of in vitro activity of ten oral antimicrobial agents against respiratory tract pathogens.

作者信息

Platsouka E, Constantoulaki S, Dimitropoulos N, Niha M, Pierros N, Dimopoulou H, Paniara O

机构信息

Dept. of Microbiology, "Evangelismos" Hospital, Athens, Greece.

出版信息

J Chemother. 1995 Nov;7 Suppl 4:58-60.

PMID:8904108
Abstract
摘要

相似文献

1
A comparison of in vitro activity of ten oral antimicrobial agents against respiratory tract pathogens.十种口服抗菌剂对呼吸道病原体的体外活性比较。
J Chemother. 1995 Nov;7 Suppl 4:58-60.
2
Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.新型大环内酯类药物氟红霉素对流感嗜血杆菌、肺炎链球菌、化脓性链球菌、卡他莫拉菌和金黄色葡萄球菌的抗菌活性。
J Chemother. 1989 Jul;1(4 Suppl):203-4.
3
In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.莫西沙星对卡塔尔社区呼吸道病原体的体外活性。
Int J Antimicrob Agents. 2004 Sep;24(3):309-10. doi: 10.1016/j.ijantimicag.2004.05.002.
4
Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.抗生素耐药时代口服β-内酰胺类抗菌药物对肺炎链球菌、流感嗜血杆菌和卡他莫拉菌呼吸道分离株的活性
Otolaryngol Head Neck Surg. 2002 Dec;127(6 Suppl):S17-23. doi: 10.1067/mhn.2002.130029.
5
Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.阿莫西林/克拉维酸药代动力学增强型口服制剂（2000/125毫克，每日两次）对2000年全球收集的9172株呼吸道分离菌的体外活性比较
Int J Infect Dis. 2004 Nov;8(6):362-73. doi: 10.1016/j.ijid.2004.02.005.
6
Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.细菌呼吸道病原体的耐药性追踪：2001 - 2005年TRUST监测计划的结果总结
Postgrad Med. 2008 Sep;120(3 Suppl 1):8-15. doi: 10.3810/pgm.2008.09.suppl52.279.
7
Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.常见呼吸道病原体的抗菌药物敏感性概况：全球视角
Postgrad Med. 2008 Sep;120(3 Suppl 1):16-24. doi: 10.3810/pgm.2008.09.suppl52.280.
8
[In vitro activity of trovafloxacin in 238 respiratory pathogens].[曲伐沙星对238种呼吸道病原体的体外活性]
Rev Esp Quimioter. 1998 Mar;11(1):47-51.
9
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).住院呼吸道感染患者细菌分离株的药敏模式（MOXIAKTIV研究）
Int J Antimicrob Agents. 2009 Jan;33(1):52-7. doi: 10.1016/j.ijantimicag.2008.07.017. Epub 2008 Oct 1.
10
Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.加拿大流感嗜血杆菌、肺炎链球菌和卡他莫拉菌分离株的抗菌药敏性测定。加拿大抗菌研究小组。
J Antimicrob Chemother. 1999 Mar;43 Suppl A:25-30.

引用本文的文献

1
Azithromycin. A review of its use in paediatric infectious diseases.阿奇霉素。其在儿科传染病中应用的综述。
Drugs. 1998 Aug;56(2):273-97. doi: 10.2165/00003495-199856020-00014.
2
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.克拉霉素。免疫功能正常患者呼吸道感染治疗中其疗效的综述。
Drugs. 1997 Jun;53(6):973-1004. doi: 10.2165/00003495-199753060-00006.